drug therapy
This suggests that additive triple DMARD       combination therapy of a low dose of sulfhydryl compounds, SSZ and MTX could be a       useful drug therapy for the treatment of RA patients, even those who are       refractory.
This suggests that additive triple DMARD       combination therapy of a low dose of sulfhydryl compounds, SSZ and MTX could be a       useful  @SUBJECT$  for the  @PREDICAT$  of  @OBJECT$  patients, even those who are       refractory.